Profilin 1 as a target for cathepsin X activity in tumor cells

PLoS One. 2013;8(1):e53918. doi: 10.1371/journal.pone.0053918. Epub 2013 Jan 10.

Abstract

Cathepsin X has been reported to be a tumor promotion factor in various types of cancer; however, the molecular mechanisms linking its activity with malignant processes are not understood. Here we present profilin 1, a known tumor suppressor, as a target for cathepsin X carboxypeptidase activity in prostate cancer PC-3 cells. Profilin 1 co-localizes strongly with cathepsin X intracellularly in the perinuclear area as well as at the plasma membrane. Selective cleavage of C-terminal amino acids was demonstrated on a synthetic octapeptide representing the profilin C-terminal region, and on recombinant profilin 1. Further, intact profilin 1 binds its poly-L-proline ligand clathrin significantly better than it does the truncated one, as shown using cathepsin X specific inhibitor AMS-36 and immunoprecipitation of the profilin 1/clathrin complex. Moreover, the polymerization of actin, which depends also on the binding of poly-L-proline ligands to profilin 1, was promoted by AMS-36 treatment of cells and by siRNA cathepsin X silencing. Our results demonstrate that increased adhesion, migration and invasiveness of tumor cells depend on the inactivation of the tumor suppressive function of profilin 1 by cathepsin X. The latter is thus designated as a target for development of new antitumor strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Cathepsin K / antagonists & inhibitors
  • Cathepsin K / genetics
  • Cathepsin K / metabolism*
  • Cell Adhesion / genetics
  • Cell Line, Tumor
  • Cell Membrane / metabolism
  • Cell Membrane / ultrastructure
  • Cell Movement / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ligands
  • Male
  • Neoplasm Invasiveness / genetics
  • Profilins / genetics
  • Profilins / metabolism*
  • Prostatic Neoplasms* / genetics
  • Prostatic Neoplasms* / metabolism
  • Prostatic Neoplasms* / pathology
  • Protein Binding
  • RNA, Small Interfering

Substances

  • Actins
  • Ligands
  • Profilins
  • RNA, Small Interfering
  • CTSK protein, human
  • Cathepsin K

Grants and funding

This work was supported by Slovenia Research Agency grant P4-0127 and J4-0123 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.